雅戈爾(600177.SH):公司出售中信股份、中信銀行、博遷新材等金融資產
格隆匯6月24日丨雅戈爾(600177.SH)公佈,根據《上海證券交易所股票上市規則》第6.1.2條、第6.1.15條的規定,上市公司發生交易事項,當連續十二個月內累計成交金額(包括承擔的債務和費用)佔上市公司最近一期經審計淨資產的10%以上,且絕對金額超過1000萬元時,應當及時履行信息披露義務。截至2025年6月23日,公司出售中信股份、中信銀行、博遷新材等金融資產,連續十二個月內累計成交金額爲417,507.46萬元,達到2024年末經審計淨資產的10.13%(以審計數據爲準),已達到上述信息披露標準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.